EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodeling

Susan M Lin, Ryan Rue, Alexander R Mukhitov, Akansha Goel, Maria C Basil, Kseniya Obraztsova, Apoorva Babu, Slaven Crnkovic, Owen A Ledwell, Laura T Ferguson, Joseph D Planer, Ana N Nottingham und 7 weitere

Journal of Clinical Investigation · 15.02.2024 · 134 (4)

DOI: 10.1172/jci172116 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 20.12.2023. Verfasst von Susan M Lin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine. Hauptthemen laut MEDLINE: Lymphangioleiomyomatosis, Tuberous Sclerosis, Tumor Suppressor Proteins, Tuberous Sclerosis Complex 2 Protein. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphangioleiomyomatosisTuberous SclerosisTumor Suppressor ProteinsTuberous Sclerosis Complex 2 ProteinAnimalsHumansInfantMiceEndothelial CellsLungMechanistic Target of Rapamycin Complex 1MesodermVascular RemodelingT-Box Domain ProteinsIn Vitro Techniques

Stichwörter der Autor:innen

Cell BiologyEndothelial cellsMouse modelsVascular Biology

Substanzen

Mechanistic Target of Rapamycin Complex 1Tumor Suppressor ProteinsTsc2 protein, mouseTbx4 protein, mouseT-Box Domain ProteinsTuberous Sclerosis Complex 2 Protein

Autor:innen und Institutionen

  • Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine.
  • Lung Biology Institute, and.
  • Penn Cardiovascular Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Physiology, Medical University of Graz, Graz, Austria.
  • Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.
  • Institute for Lung Health, Justus-Liebig University Giessen, Giessen, Germany.

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • NHLBI

Zitieren

APA

Lin, S. M., Rue, R., Mukhitov, A. R., Goel, A., Basil, M. C., Obraztsova, K., Babu, A., Crnkovic, S., Ledwell, O. A., Ferguson, L. T., Planer, J. D., Nottingham, A. N., Vanka, K. S., Smith, C. J., Cantu, E., Kwapiszewska, G., Morrisey, E. E., Evans, J. F., & Krymskaya, V. P. (2024). Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodeling. Journal of Clinical Investigation, 134(4). https://doi.org/10.1172/jci172116

Vancouver

Lin SM, Rue R, Mukhitov AR, Goel A, Basil MC, Obraztsova K, et al. Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodeling. Journal of Clinical Investigation. 2024;134(4). doi:10.1172/jci172116

BibTeX
@article{Lin2024,
  author = {Lin, Susan M and Rue, Ryan and Mukhitov, Alexander R and Goel, Akansha and Basil, Maria C and Obraztsova, Kseniya and Babu, Apoorva and Crnkovic, Slaven and Ledwell, Owen A and Ferguson, Laura T and Planer, Joseph D and Nottingham, Ana N and Vanka, Kanth Swaroop and Smith, Carly J and Cantu, Edward and Kwapiszewska, Grazyna and Morrisey, Edward E and Evans, Jillian F and Krymskaya, Vera P},
  title = {Hyperactive mTORC1 in lung mesenchyme induces endothelial cell dysfunction and pulmonary vascular remodeling},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  volume = {134},
  number = {4},
  doi = {10.1172/jci172116}
}
Kostenlos starten →